Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cortes

Showing results (231-240 of 232) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 232 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 TrialHope S Rugo, Seock-Ah Im, Fatima Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Pageof 24

Showing results (231-240 of 232) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 232 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 TrialHope S Rugo, Seock-Ah Im, Fatima Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Pageof 24